Company Offers Unit which can Verify Drug Ingredients
Released on: April 10, 2008, 7:16 am
Press Release Author: Michael DeBoer/XStream Systems, Inc.
Industry: Pharmaceuticals
Press Release Summary: XStream Systems, Inc., a pharmaceutical authentication company, offers their product which can verify drug ingredients and protect our supply chain against adulterated or counterfeit materials.
Press Release Body: A pharmaceutical authentication company is now selling equipment which can verify drug ingredients outside of a laboratory. XStream Systems, Inc. offers a unit which can read the molecular structure of medicines without having to open any packaging or break a bottle's seal.
Named the XT250 System, its underlying technology was originally developed to protect the public from terrorist threats, but has since found its role in the pharmaceutical industry. It can tell if a drug is counterfeit, altered, contaminated, or otherwise different on a molecular level from its intended form.
"This unit is of great benefit when dealing with drugs or ingredients from questionable sources, such as what we've seen from China in the recent Heparin incident," stated John Lundquist, VP of Business Development for XStream Systems. "The fact it can test drugs when they are still in the manufacturer's packaging makes the system even more valuable to companies trying to keep their outbound shipments clean."
The XT250 System is currently being used at multiple locations in the pharmaceutical supply network, checking inventories for dangerous products.
XStream Systems, Inc. XStream Systems produces next-generation equipment for material identification. Their patented systems are based on Energy-Dispersive X-Ray Diffraction (EDXRD) technology. The company's XT250T System enables testing of powders, pills AND entire sealed bottles. The equipment's superior sample penetration allows the identification of contents inside opaque plastic, cardboard and even metal packaging. For more information, call 1-800-597-1191, visit www.securepharmachain.com or www.securepharmablog.com.
2025
